Ospedale Madonna delle Grazie - Ematologia
About Ospedale Madonna delle Grazie - Ematologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Fondazione Italiana Linfomi ONLUS
8
Celgene
2
Clinical Trials at Ospedale Madonna delle Grazie - Ematologia
During the past decade, Ospedale Madonna delle Grazie - Ematologia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
2008-08-21
2016-07-14
Completed
1,623
Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma
2005-12-01
2014-03-01
Unknown status
534
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
2009-05-01
2011-05-01
Completed
1,927
Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM
2014-04-30
2020-10-12
Completed
46
Indolent Non Follicular Lymphomas Prognostic Project
2011-09-01
2024-09-01
Active, not recruiting
370
FIL Study on ABVD DD-DI as Upfront Therapy in HL.
2017-08-01
2023-01-01
Active, not recruiting
500
Study on the Role of FDG-PET in Patients With FL at Time of Relapse/Progression
2016-05-01
2019-12-30
Completed
175
Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis
2018-08-10
2026-01-01
Recruiting
400
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Ospedale Madonna delle Grazie - Ematologia
According to Clinical.Site data, the most researched conditions in "Ospedale Madonna delle Grazie - Ematologia" are
"Follicular Lymphoma" (3 trials), "Multiple Myeloma" (2 trials), "B-Cell Lymphomas" (1 trials), "Classical Hodgkin Lymphoma" (1 trials) and "Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Ospedale Madonna delle Grazie - Ematologia" in a lesser frequency.
Clinical Trials Intervention Types at Ospedale Madonna delle Grazie - Ematologia
Most popular intervention types in "Ospedale Madonna delle Grazie - Ematologia" are "Drug" (5 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Any treatment, watch and wait policy included" (1 trials), "Bleomycin" (1 trials), "Dacarbazine" (1 trials), "Doxorubicin" (1 trials) and "Immunochemotherapy regimen: G-CHOP (Arm A)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ospedale Madonna delle Grazie - Ematologia
The vast majority of trials in "Ospedale Madonna delle Grazie - Ematologia" are
10 trials for "All" genders.
Clinical Trials Status at Ospedale Madonna delle Grazie - Ematologia
Currently, there are NaN active trials in "Ospedale Madonna delle Grazie - Ematologia".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Ospedale Madonna delle Grazie - Ematologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ospedale Madonna delle Grazie - Ematologia, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".